These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 13647435)

  • 21. [Pharmacodynamics of erythromycin lactobionate during tonsillectomy in children].
    Leuthardt R; Trümpi B; Morger R
    Schweiz Med Wochenschr; 1989 Oct; 119(40):1372-4. PubMed ID: 2799345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Administration of antibiotics in combination. Determination of antibacterial effectivity of blood serum and urine after simultaneous administration of macrolides and tetracyclines.
    Janovska D; Vymola F; Godova T
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(4):481-8. PubMed ID: 1035924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on macrolide antibiotics I. Synthesis and antibacterial activity of erythromycin A 9-O-substituted oxime ether derivatives against Mycobacterium avium complex.
    Nishimoto A; Narita K; Ohmoto S; Takahashi Y; Yoshizumi S; Yoshida T; Kado N; Okezaki E; Kato H
    Chem Pharm Bull (Tokyo); 2001 Sep; 49(9):1120-7. PubMed ID: 11558597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibiotics of the erythromycin group].
    CAGNOLATI G
    Corr Farm; 1961 Dec 1-15; 16():456-9. PubMed ID: 13875528
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemical modification of erythromycin antibiotics. 4. Structure-activity relationships of erythromycin esters.
    Martin YC; Jones PH; Perun TJ; Grundy WE; Bell S; Bower RR; Shipkowitz NL
    J Med Chem; 1972 Jun; 15(6):635-8. PubMed ID: 4555493
    [No Abstract]   [Full Text] [Related]  

  • 26. Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
    Jakubů V; Zavadilová J; Fabiánová K; Urbášková P
    Cent Eur J Public Health; 2017 Dec; 25(4):282-286. PubMed ID: 29346850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the sensitivity of bacteria to combinations of antibiotics in vitro; discussion of some results, especially with the combination tetracyclin-erythromycin.
    OSKAM HJ
    Acta Med Scand; 1956 Oct; 155(5):335-51. PubMed ID: 13372188
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.
    Seppälä H; Klaukka T; Vuopio-Varkila J; Muotiala A; Helenius H; Lager K; Huovinen P
    N Engl J Med; 1997 Aug; 337(7):441-6. PubMed ID: 9250845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The erythromycin group of antibiotics.
    GARROD LP
    Br Med J; 1957 Jul; 2(5036):57-63. PubMed ID: 13436854
    [No Abstract]   [Full Text] [Related]  

  • 30. Toxic effects of erythromycin, ciprofloxacin and sulfamethoxazole on photosynthetic apparatus in Selenastrum capricornutum.
    Liu BY; Nie XP; Liu WQ; Snoeijs P; Guan C; Tsui MT
    Ecotoxicol Environ Saf; 2011 May; 74(4):1027-35. PubMed ID: 21353704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic interactions of the macrolide antibiotics.
    Ludden TM
    Clin Pharmacokinet; 1985; 10(1):63-79. PubMed ID: 3882305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dental therapeutic indications for the newer long-acting macrolide antibiotics.
    Moore PA
    J Am Dent Assoc; 1999 Sep; 130(9):1341-3. PubMed ID: 10492541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythromycin and the treatment of Coxiella burnetii pneumonia.
    Pérez-del-Molino A; Aguado JM; Riancho JA; Sampedro I; Matorras P; Gonzalez-Macias J
    J Antimicrob Chemother; 1991 Sep; 28(3):455-9. PubMed ID: 1960125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis.
    Lanbeck P; Odenholt I; Riesbeck K
    J Antimicrob Chemother; 2004 Feb; 53(2):174-9. PubMed ID: 14729754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible inhibition of hepatic metabolism of quinidine by erythromycin.
    Spinler SA; Cheng JW; Kindwall KE; Charland SL
    Clin Pharmacol Ther; 1995 Jan; 57(1):89-94. PubMed ID: 7828386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythromycin assay: specificity of determining erythromycin A in relation to erythromycin B.
    Chatterjee NR; Badve VM
    Hindustan Antibiot Bull; 1983; 25(3-4):131-4. PubMed ID: 6674276
    [No Abstract]   [Full Text] [Related]  

  • 38. DRUG ANTAGONISM BETWEEN LINCOMYCIN AND ERYTHROMYCIN.
    GRIFFITH LJ; OSTRANDER WE; MULLINS CG; BESWICK DE
    Science; 1965 Feb; 147(3659):746-7. PubMed ID: 14242023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythromycin is ineffective against Listeria monocytogenes in multidrug resistant cells.
    Nichterlein T; Kretschmar M; Siegsmund M; Hof H
    J Chemother; 1995 Jun; 7(3):184-8. PubMed ID: 7562011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythromycin and related antibiotics; applied pharmacology.
    SHOEMAKER EH; YOW EM
    Pediatr Clin North Am; 1956 May; ():305-15. PubMed ID: 13370177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.